One previous study (17) demonstrated that CD47 is upregulated in AML and blastic phase CML, but not in other myeloproliferative disorders, including PV, post-PV MF, ET, and PMF (n=5). The gene discussed is CD47; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.